Rhonda L. Hellums's most recent trade in Silence Therapeutics Plc - ADR was a trade of 375,000 Employee Share Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Silence Therapeutics Plc ADR | Rhonda L. Hellums | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 375,000 | 375,000 | - | - | Employee Share Option (Right to Buy) |